Teva Shares Flat After Company Reported Positive Results from Phase III Study to Evaluate Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237)
April 30, 2014 at 10:48 AM EDT
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced positive results from a pivotal Phase III study of hydrocodone ...
